Date: 15 November 2021
Time: 10-17 CET
The workshop will examine personalised medicine primarily from a research perspective. Four sessions will be dedicated to next generation technologies and the challenges they present, personalised oncology, the orientation of pharmacogenetics towards treatment options, and national programs to introduce personalised therapies to citizens.
The workshop will bring together a critical mass of experts in the field of personalised medicine with the aim of an intensive exchange of information and networking. The workshop is organised by the Paul-Ehrlich-Institute in Germany and endorsed by ICPerMed.
More information, the detailed programme and the registration link are available here.
The Paul-Ehrlich-Institute, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main , Germany, is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.